Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MECHLORETHAMINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 43 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ferry, DM; van Zijl, PL; Wilson, WR
      Sensitive liquid chromatographic assay for the basic DNA intercalator (N,N-dimethylaminoethyl)-9-amino-5-methylacridine-4-carboxamide and its nitroarylmethyl quaternary prodrugs in biological samples

      JOURNAL OF CHROMATOGRAPHY B
    2. Millard, JT; Wilkes, EE
      Diepoxybutane and diepoxyoctane interstrand cross-linking of the 5S DNA nucleosomal core particle

      BIOCHEMISTRY
    3. Romero, RM; Rojsitthisak, P; Haworth, IS
      DNA interstrand crosslink formation by mechlorethamine at a cytosine-cytosine mismatch pair: Kinetics and sequence dependence

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    4. Rappeneau, S; Baeza-Squiban, A; Marano, F; Calvet, JH
      Efficient protection of human bronchial epithelial cells against sulfur and nitrogen mustard cytotoxicity using drug combinations

      TOXICOLOGICAL SCIENCES
    5. Rappeneau, S; Baeza-Squiban, A; Jeulin, C; Marano, F
      Protection from cytotoxic effects induced by the nitrogen mustard mechlorethamine on human bronchial epithelial cells in vitro

      TOXICOLOGICAL SCIENCES
    6. Snell, J; Lillquist, DR; Lewis-Younger, C; Wallace, DO
      Exposure at home to airborne concentrations of nitrogen mustard during topical application for the treatment of mycosis fungoides: A case study

      DERMATOLOGY
    7. Turner, PR; Denny, WA; Ferguson, LR
      Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards

      ANTI-CANCER DRUG DESIGN
    8. Wormser, U; Brodsky, B; Green, BS; Arad-Yellin, R; Nyska, A
      Protective effect of povidone iodine ointment against skin lesions inducedby chemical and thermal stimuli

      JOURNAL OF APPLIED TOXICOLOGY
    9. Wormser, U; Brodsky, B; Green, BS; Arad-Yellin, R; Nyska, A
      Protective effect of povidone iodine ointment against skin lesions inducedby chemical and thermal stimuli

      JOURNAL OF APPLIED TOXICOLOGY
    10. Aglietta, M; Montemurro, F; Fagioli, F; Volta, C; Botto, B; Cantonetti, M; Racanelli, V; Teofili, L; Ferrara, R; Amadori, S; Castoldi, GL; Dammacco, F; Levis, A
      Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease

      CANCER
    11. Hoeger, PH; Nanduri, VR; Harper, JI; Atherton, DA; Pritchard, J
      Long term follow up of topical mustine treatment for cutaneous Langerhans cell histiocytosis

      ARCHIVES OF DISEASE IN CHILDHOOD
    12. Everett, SA; Naylor, MA; Patel, KB; Stratford, MRL; Wardman, P
      Bioreductively-activated prodrugs for targeting hypoxic tissues: Elimination of aspirin from 2-nitroimidazole derivatives

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    13. Jiang, SB; Dietz, SB; Kim, M; Lim, HW
      Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-yearexperience

      PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE
    14. Calvet, JH; Feuermann, M; Llorente, B; Loison, F; Harf, A; Marano, F
      Comparative toxicity of sulfur mustard and nitrogen mustard on tracheal epithelial cells in primary culture

      TOXICOLOGY IN VITRO
    15. Rappeneau, S; Baeza-Squiban, A; Braut-Boucher, F; Aubery, M; Gendron, MC; Marano, F
      Use of fluorescent probes to assess the early sulfhydryl depletion and oxidative stress induced by mechlorethamine human bronchial epithelial cells

      TOXICOLOGY IN VITRO
    16. Brandes, AA; Ermani, M; Turazzi, S; Scelzi, E; Berti, F; Amista, P; Rotilio, A; Licata, C; Fiorentino, MV
      Procarbazine and high-dose tamoxifen as a second-line regimen in recurrenthigh-grade gliomas: A phase II study

      JOURNAL OF CLINICAL ONCOLOGY
    17. Kim, YH; Hoppe, RT
      Mycosis fungoides and the Sezary syndrome

      SEMINARS IN ONCOLOGY
    18. STALLMEISTER T; DIECKMANN K; REHBERGER A; JURECKA W
      LONG-TERM REMISSION OF TUMOR-STAGE MYCOSIS-FUNGOIDES FOLLOWING TOTAL-SKIN ELECTRON-BEAM RADIOTHERAPY

      EJD. European journal of dermatology
    19. WILSON LD; KACINSKI BM; JONES GW
      LOCAL SUPERFICIAL RADIOTHERAPY IN THE MANAGEMENT OF MINIMAL STAGE IA CUTANEOUS T-CELL LYMPHOMA (MYCOSIS-FUNGOIDES)

      International journal of radiation oncology, biology, physics
    20. ZACKHEIM HS; KASHANISABET M; AMIN S
      TOPICAL CORTICOSTEROIDS FOR MYCOSIS-FUNGOIDES - EXPERIENCE IN 79 PATIENTS

      Archives of dermatology
    21. NAJMANBRONZEWSKA L; OCHOCKI J
      IN-VITRO ALKYLATING OF ALPHA,BETA-UNSATURATED AMIDOESTERS, DIETHYL PYRIDYLMETHYLPHOSPHONATES AND THEIR CIS-PT(II) COMPLEXES

      Die Pharmazie
    22. DALTON JA; YAGHOWARD C; MESSINA JL; GLASS LF
      CUTANEOUS T-CELL LYMPHOMA

      International journal of dermatology
    23. LEHMANN DF; HURTEAU TE; NEWMAN N; COYLE TE
      ANTICONVULSANT USAGE IS ASSOCIATED WITH AN INCREASED RISK OF PROCARBAZINE HYPERSENSITIVITY REACTIONS IN PATIENTS WITH BRAIN-TUMORS

      Clinical pharmacology and therapeutics
    24. YUNES MJ; CHARNECKI SE; MARDEN JJ; MILLARD JT
      1,2,5,6-DIEPOXYHEXANE AND 1,2,7,8-DIEPOXYOCTANE CROSS-LINK DUPLEX DNAAT 5'-GNC SEQUENCES

      Chemical research in toxicology
    25. MILLARD JT; LUEDTKE NW; SPENCER RJ
      THE 5'-GNC PREFERENCE FOR MUSTARD CROSS-LINKING IS PRESERVED IN A RESTRICTION FRAGMENT

      Anti-cancer drug design
    26. REDDY VB; RAMSAY D; GARCIA JA; KAMINO H
      ATYPICAL CUTANEOUS CHANGES AFTER TOPICAL TREATMENT WITH NITROGEN-MUSTARD IN PATIENTS WITH MYCOSIS-FUNGOIDES

      The American journal of dermatopathology
    27. DUVIC M; LEMAK NA; REDMAN JR; EIFEL PJ; TUCKER SL; CABANILLAS FF; KURZROCK R
      COMBINED-MODALITY THERAPY FOR CUTANEOUS T-CELL LYMPHOMA

      Journal of the American Academy of Dermatology
    28. BRYNIARSKI K; PTAK M; PTAK W
      THE IN-VIVO AND IN-VITRO EFFECTS OF AN ALKYLATING AGENT, MECHLORETHAMINE, ON IL-6 PRODUCTION IN MICE AND THE ROLE OF MACROPHAGES

      Immunopharmacology
    29. POPESCU MA; SHEEHAN MG; KOUIDES PA; LOUGHNER JE; CONDEMI JJ; LOONEY RJ; LEDDY JP
      ALLERGIC REACTIONS TO CYCLOPHOSPHAMIDE - DELAYED CLINICAL EXPRESSION ASSOCIATED WITH POSITIVE IMMEDIATE SKIN-TESTS TO DRUG METABOLITES IN 5PATIENTS

      Journal of allergy and clinical immunology
    30. DIAMANDIDOU E; COHEN PR; KURZROCK R
      MYCOSIS-FUNGOIDES AND SEZARY-SYNDROME

      Blood
    31. RAMSAY DL; MELLER JA; ZACKHEIM HS
      TOPICAL TREATMENT OF EARLY CUTANEOUS T-CELL LYMPHOMA

      Hematology/oncology clinics of North America
    32. GULICK AM; FAHL WE
      FORCED EVOLUTION OF GLUTATHIONE-S-TRANSFERASE TO CREATE A MORE EFFICIENT DRUG DETOXICATION ENZYME

      Proceedings of the National Academy of Sciences of the United Statesof America
    33. DENNY WA; WILSON WR; TERCEL M; VANZIJL P; PULLEN SM
      NITROBENZYL MUSTARD QUATERNARY-SALTS - A NEW CLASS OF HYPOXIA-SELECTIVE CYTOTOXINS CAPABLE OF RELEASING DIFFUSIBLE CYTOTOXINS ON BIOREDUCTION

      International journal of radiation oncology, biology, physics
    34. ZHANG XW; HUANG ZQ; LI CC
      ANTITUMOR-ACTIVITY OF THEVETOSIDE ALONE A ND IN COMBINATION WITH CHLORMETHINE IN-VIVO

      Zhongguo yaoli xuebao
    35. SMOLLER BR; MARCUS R
      RISK OF SECONDARY CUTANEOUS MALIGNANCIES IN PATIENTS WITH LONG-STANDING MYCOSIS-FUNGOIDES

      Journal of the American Academy of Dermatology
    36. HADFIELD PJ; BIRCHALL MA; ALBERT DM
      OTITIS-EXTERNA IN LANGERHANS CELL HISTIOCYTOSIS - THE SUCCESSFUL USE OF TOPICAL NITROGEN-MUSTARD

      International journal of pediatric otorhinolaryngology
    37. POVIRK LF; SHUKER DE
      DNA-DAMAGE AND MUTAGENESIS INDUCED BY NITROGEN MUSTARDS

      Mutation research. Reviews in genetic toxicology
    38. RAPPERSBERGER K; ORTEL B; FORSTINGER C; WOLFF K
      TREATMENT OF CUTANEOUS T-CELL LYMPHOMAS

      Wiener Klinische Wochenschrift
    39. FIVENSON DP; SAED GM; BECK ER; DUNSTAN RW; MOORE PF
      T-CELL RECEPTOR GENE REARRANGEMENT IN CANINE MYCOSIS-FUNGOIDES - FURTHER SUPPORT FOR A CANINE MODEL OF CUTANEOUS T-CELL LYMPHOMA

      Journal of investigative dermatology
    40. KNYSAK DJ; MCLEAN JA; SOLOMON WR; FOX DA; MCCUNE WJ
      IMMEDIATE HYPERSENSITIVITY REACTION TO CYCLOPHOSPHAMIDE

      Arthritis and rheumatism
    41. HARTLEY JA; SOUHAMI RL; BERARDINI MD
      ELECTROPHORETIC AND CHROMATOGRAPHIC-SEPARATION METHODS USED TO REVEALINTERSTRAND CROSS-LINKING OF NUCLEIC-ACIDS

      Journal of chromatography. Biomedical applications
    42. LEIGH BR; FOX KA; MACK CF; BAIER M; MILLER TP; CASSADY JR
      RADIATION-THERAPY SALVAGE OF HODGKINS-DISEASE FOLLOWING CHEMOTHERAPY FAILURE

      International journal of radiation oncology, biology, physics
    43. MOSTOW EN; NECKEL SL; OBERHELMAN L; ANDERSON TF; COOPER KD
      COMPLETE REMISSIONS IN PSORALEN AND UV-A (PUVA) REFRACTORY MYCOSIS-FUNGOIDES TYPE CUTANEOUS T-CELL LYMPHOMA WITH COMBINED INTERFERON-ALFA AND PUVA

      Archives of dermatology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 03:32:09